Zacks Investment Management’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-29,228
Closed -$1.55M – 575
2019
Q3
$1.55M Buy
29,228
+19,951
+215% +$1.03M 0.03% 313
2019
Q2
$491K Buy
9,277
+4,355
+88% +$232K 0.01% 456
2019
Q1
$278K Buy
+4,922
New +$276K 0.01% 493
2018
Q2
– Sell
-39,481
Closed -$2.32M – 581
2018
Q1
$2.32M Buy
39,481
+1,166
+3% +$65.3K 0.05% 235
2017
Q4
$2.1M Buy
38,315
+3,053
+9% +$158K 0.05% 254
2017
Q3
$1.67M Buy
+35,262
New +$1.66M 0.04% 276

Other funds holding OFIX

Zacks Investment Management's OFIX Position: Q4 2019 in Review

Zacks Investment Management sold out of Orthofix Medical (OFIX) in Q4 2019, closing a stake of 29,228 shares — an estimated $1.55M sold.

Zacks Investment Management first reported a position in OFIX in Q3 2017 and held it in 6 quarters. The position peaked at $2.32M in Q1 2018. 157 funds tracked by Wall St. Rank hold OFIX as of Q4 2019.

  • Zacks Investment Management reported no remaining Orthofix Medical position as of Q4 2019 after selling out during the quarter.
  • Zacks Investment Management sold 29,228 Orthofix Medical shares in Q4 2019, an estimated $1.55M.
  • Zacks Investment Management first reported a position in Orthofix Medical in Q3 2017 and held it in 6 quarters.
  • Zacks Investment Management's Orthofix Medical position peaked at $2.32M in Q1 2018.
  • 157 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2019.

Based on Zacks Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.